Refining the role of pms2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants

Background and aim The majority of mismatch repair (MMR) gene mutations causing Lynch syndrome (LS) occur either in MLH1 or MSH2. However, the relative contribution of PMS2 is less well defined. The aim of this study was to evaluate the role of PMS2 in LS by assessing the pathogenicity of variants of unknown significance (VUS) detected in the mutational analysis of PMS2 in a series of Spanish patients. Methods From a cohort of 202 LS suspected patients, 13 patients showing loss of PMS2 expression in tumours were screened for germline mutations in PMS2, using a long range PCR based strategy and multiplex ligation dependent probe amplification (MLPA). Pathogenicity assessment of PMS2 VUS was performed evaluating clinicopathological data, frequency in control population and in silico and in vitro analyses at the RNA and protein level. Results Overall 25 different PMS2 DNA variants were detected. Fourteen were classified as polymorphisms. Nine variants were classified as pathogenic: seven alterations based on their molecular nature and two after demonstrating a functional defect (c.538-3C>G affected mRNA processing and c.137G>T impaired MMR activity). The c.1569C>G variant was classified as likely neutral while the c.384G>A remained as a VUS. We have also shown that the polymorphic variant c.59G>A is MMR proficient. Conclusions Pathogenic PMS2 mutations were detected in 69% of patients harbouring LS associated tumours with loss of PMS2 expression. In all, PMS2 mutations account for 6% of the LS cases identified. The comprehensive functional analysis shown here has been useful in the classification of PMS2 VUS and contributes to refining the role of PMS2 in LS.

[1]  J. Hopper,et al.  Recurrent and founder mutations in the PMS2 gene , 2013, Clinical genetics.

[2]  Steven Gallinger,et al.  A Multifactorial Likelihood Model for MMR Gene Variant Classification Incorporating Probabilities Based on Sequence Bioinformatics and Tumor Characteristics: A Report from the Colon Cancer Family Registry , 2013, Human mutation.

[3]  Predrag Radivojac,et al.  Calibration of Multiple In Silico Tools for Predicting Pathogenicity of Mismatch Repair Gene Missense Substitutions , 2013, Human mutation.

[4]  N. de Wind,et al.  Functional characterization of MLH1 missense variants identified in lynch syndrome patients , 2012, Human mutation.

[5]  Christopher D. Heinen,et al.  Pathological assessment of mismatch repair gene variants in Lynch syndrome: Past, present, and future , 2012, Human mutation.

[6]  C. Lázaro,et al.  Comprehensive functional assessment of MLH1 variants of unknown significance , 2012, Human mutation.

[7]  P. Devilee,et al.  Insertion of an SVA element, a nonautonomous retrotransposon, in PMS2 intron 7 as a novel cause of lynch syndrome , 2012, Human mutation.

[8]  Xinru Wang,et al.  Common variants in mismatch repair genes associated with increased risk of sperm DNA damage and male infertility , 2012, BMC Medicine.

[9]  M. Baudis,et al.  Improved Multiplex Ligation-Dependent Probe Amplification Analysis Identifies a Deleterious PMS2 Allele Generated by Recombination with Crossover Between PMS2 and PMS2CL , 2012, Genes, chromosomes & cancer.

[10]  J. Swensen,et al.  Avoidance of pseudogene interference in the detection of 3′ deletions in PMS2 , 2011, Human mutation.

[11]  A. Gonzalez-Perez,et al.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.

[12]  J. Trojan,et al.  A CRM1‐dependent nuclear export pathway is involved in the regulation of MutLα subcellular localization , 2011, Genes, chromosomes & cancer.

[13]  A. Viel,et al.  Integrated analysis of unclassified variants in mismatch repair genes , 2011, Genetics in Medicine.

[14]  A. Pollett,et al.  A novel and rapid method of determining the effect of unclassified MLH1 genetic variants on differential allelic expression. , 2010, The Journal of molecular diagnostics : JMD.

[15]  J. Bujnicki,et al.  Identification of Lynch syndrome mutations in the MLH1–PMS2 interface that disturb dimerization and mismatch repair , 2010, Human mutation.

[16]  R. Scott,et al.  MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer , 2010, Hereditary cancer in clinical practice.

[17]  A. Green,et al.  Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of lynch syndrome patients , 2010, Human mutation.

[18]  Pinar Bayrak-Toydemir,et al.  Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes , 2010, Human mutation.

[19]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[20]  John L Hopper,et al.  Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics , 2009, Human mutation.

[21]  H. Hollema,et al.  PMS2 involvement in patients suspected of Lynch syndrome , 2009, Genes, chromosomes & cancer.

[22]  F. Couch,et al.  Prediction and assessment of splicing alterations: implications for clinical testing , 2008, Human mutation.

[23]  R. Kolodner,et al.  Apoptotic function of human PMS2 compromised by the nonsynonymous single-nucleotide polymorphic variant R20Q , 2008, Proceedings of the National Academy of Sciences.

[24]  J. Potter,et al.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. , 2008, Gastroenterology.

[25]  A. Pollett,et al.  Café‐au‐lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2 , 2008, Pediatric blood & cancer.

[26]  J. Hainfellner,et al.  RNA‐based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference , 2008, Human mutation.

[27]  L. F. Engebretsen,et al.  A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts , 2008, Familial Cancer.

[28]  H. Vasen.  Review article: the Lynch syndrome (hereditary nonpolyposis colorectal cancer) * , 2007, Alimentary pharmacology & therapeutics.

[29]  J. Saurin,et al.  Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation , 2007, Human mutation.

[30]  Lise Getoor,et al.  SplicePort—An interactive splice-site analysis tool , 2007, Nucleic Acids Res..

[31]  R. Liskay,et al.  The E705K mutation in hPMS2 exerts recessive, not dominant, effects on mismatch repair. , 2007, Cancer letters.

[32]  Thomas Lengauer,et al.  Mutations in the MutSα interaction interface of MLH1 can abolish DNA mismatch repair , 2006, Nucleic acids research.

[33]  W. Frankel,et al.  Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. , 2006, Cancer research.

[34]  A. de la Chapelle,et al.  Long‐range PCR facilitates the identification of PMS2‐specific mutations , 2006, Human mutation.

[35]  E. Guinó,et al.  Polymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal Cancer , 2006, Clinical Cancer Research.

[36]  A. Wagner,et al.  Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). , 2006, Gastroenterology.

[37]  P. Møller,et al.  Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC) , 2005, Genes, chromosomes & cancer.

[38]  Thaned Kangsamaksin,et al.  Exon Inclusion Is Dependent on Predictable Exonic Splicing Enhancers , 2005, Molecular and Cellular Biology.

[39]  W. Frankel,et al.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.

[40]  G. Suthers,et al.  Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancer. , 2005, Gastroenterology.

[41]  Josef Jiricny,et al.  Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. , 2005, Gastroenterology.

[42]  P. Peltomäki,et al.  Mutations Associated with HNPCC Predisposition — Update of ICG-HNPCC/INSiGHT Mutation Database , 2004, Disease markers.

[43]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[44]  D. Bonthron,et al.  Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. , 2004, American journal of human genetics.

[45]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[46]  Jinhua Wang,et al.  ESEfinder: a web resource to identify exonic splicing enhancers , 2003, Nucleic Acids Res..

[47]  R. Liskay,et al.  Contribution of Human Mlh1 and Pms2 ATPase Activities to DNA Mismatch Repair* , 2002, The Journal of Biological Chemistry.

[48]  J. Jiricny,et al.  Mutations within the hMLH1 and hPMS2 Subunits of the Human MutLα Mismatch Repair Factor Affect Its ATPase Activity, but Not Its Ability to Interact with hMutSα* , 2002, The Journal of Biological Chemistry.

[49]  S. Henikoff,et al.  Accounting for human polymorphisms predicted to affect protein function. , 2002, Genome research.

[50]  W. Foulkes,et al.  Polymorphisms and HNPCC: PMS2‐MLH1 protein interactions diminished by single nucleotide polymorphisms , 2002, Human mutation.

[51]  K. Kinzler,et al.  The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. , 2001, Cancer research.

[52]  Victor V. Solovyev,et al.  SpliceDB: database of canonical and non-canonical mammalian splice sites , 2001, Nucleic Acids Res..

[53]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.

[54]  David Haussler,et al.  Improved splice site detection in Genie , 1997, RECOMB '97.

[55]  R. Foà,et al.  Microsatellite instability is associated with the histological features of the tumor in nonfamilial colorectal cancer. , 1996, Cancer research.

[56]  Peter G. Korning,et al.  Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. , 1996, Nucleic acids research.

[57]  R. Amann,et al.  Predictive Identification of Exonic Splicing Enhancers in Human Genes , 2022 .